NBIX earnings
Neurocrine Biosciences (NBIX) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.
NBIX earnings history
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q2 2026 | Jul 30, 2026 | 2.85 | 1.85 | 54.05% | $959.00M |
| Q1 2026 | May 5, 2026 | 1.91 | 1.22 | 56.56% | $814.50M |
| Q4 2025 | Feb 11, 2026 | 1.88 | 1.80 | 4.44% | $805.50M |
| Q3 2025 | Oct 28, 2025 | 2.04 | 1.58 | 29.11% | $794.90M |
| Q2 2025 | Jul 30, 2025 | 1.06 | 0.98 | 8.16% | $687.50M |
| Q1 2025 | May 5, 2025 | 0.08 | 0.54 | -85.05% | $572.60M |
| Q4 2024 | Feb 6, 2025 | 1.00 | 1.62 | -38.27% | $627.70M |
| Q3 2024 | Oct 30, 2024 | 1.24 | 1.51 | -17.88% | $622.10M |
| Q2 2024 | Aug 1, 2024 | 0.63 | 1.05 | -40.00% | $590.20M |
| Q1 2024 | May 1, 2024 | 0.42 | 1.01 | -58.42% | $515.30M |
| Q4 2023 | Feb 7, 2024 | 1.44 | 1.15 | 25.22% | $515.20M |
| Q3 2023 | Oct 31, 2023 | 0.82 | 0.97 | -15.46% | $498.80M |
| Aug 1, 2023 | 0.95 | 0.78 | 21.79% | – | |
| May 3, 2023 | -0.79 | 0.26 | -403.85% | – | |
| Feb 6, 2023 | 0.88 | 1.16 | -24.14% | – | |
| Nov 1, 2022 | 0.69 | 0.79 | -12.66% | – | |
| Aug 4, 2022 | -0.18 | 0.56 | -132.14% | – | |
| May 4, 2022 | 0.14 | 0.35 | -60.00% | – | |
| Feb 11, 2022 | -0.08 | 0.61 | -113.11% | – | |
| Nov 1, 2021 | 0.23 | 0.51 | -54.90% | – |
- NBIX reports next on Nov 2, 2026, with EPS of 1.97 expected.
- NBIX beat EPS estimates in 70 of its last 119 reports.
Updated 2026-11-02 23:14 UTC